KCTD17 Activators would be defined as a class of chemical compounds designed to specifically increase the biological activity or expression of the protein KCTD17, which is a member of the potassium channel tetramerization domain-containing (KCTD) family. These activators could work by engaging with the protein itself or interacting with cellular pathways that control the transcription and translation of the KCTD17 gene. Owing to the role of KCTD proteins in various cellular processes, these activators would likely exert their effects by modulating the physiological pathways that KCTD17 is involved in, such as those governing ion channel regulation or signal transduction.
The chemical structure of KCTD17 activators could be diverse, encompassing a range of small organic molecules, inorganic compounds, or even biopolymers that do not fall into the category of peptides, proteins, or antibodies. These molecules would be characterized by their ability to bind to specific sites on the KCTD17 protein or associated regulatory elements, leading to a conformational change that increases the protein's stability or alters its interaction with other cellular components. Alternatively, they might influence the gene expression machinery directly, for instance, by interacting with promoter regions of the KCTD17 gene or by modulating the activity of transcription factors or epigenetic markers that regulate KCTD17 expression. The precise molecular mechanisms of such activators would depend on their structure and the specific biological pathway they are designed to target
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, potentially increasing cyclic AMP levels and promoting transcription of cAMP-responsive genes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts on nuclear receptors, which might lead to changes in gene expression, including the KCTD17 gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases, potentially leading to a more open chromatin structure and increased gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can inhibit DNA methyltransferases, potentially leading to demethylation of gene promoter regions and increased gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences glycogen synthase kinase 3 (GSK-3) activity, which could affect several transcription factors and gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that could lead to changes in chromatin structure and gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is an HDAC inhibitor that can alter chromatin structure and potentially affect gene expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 inhibits TGF-beta signaling, which could impact the transcription of certain genes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, potentially affecting protein synthesis and gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone acts on glucocorticoid receptors, which may lead to alterations in the expression of certain genes. | ||||||